Part of US based
Semler Group of Companies,
in business since 1946


YOU ARE HERE: Home Pharmaceutical Development Experience

ANDA US Market

  • Delayed Release Tablet Formulation.
  • Immediate Release Tablet Formulation
  • Extended Release Matrix Tablets.
  • Ophthalmic Suspension
  • Ophthalmic Ointment

505 B (2)

  • Fixed Dose Combination Capsule
  • Fixed Dose Combination Extended Release Formulation


  • Effervescent Formulation Lubrication Optimizations Studies
  • Compression Coating (Tablet in Tablet) Formulation
  • Liposomal formulation



About This Service

SRC offers top-notch scientific expertise across dosage forms and modes of administration. Our scientists have several decades of experience in developing products for US, EU, India, Brazilian, Turkish, South African & other markets across diverse therapeutic areas.